Double Dissociation of the Roles of Metabotropic Glutamate Receptor 5 and Oxytocin Receptor in Discrete Social Behaviors

Neuropsychopharmacology

Volumn 40, Issue 10, 2015, Pages 2337-2346

  Mesic, Ivana ^a   Guzman, Yomayra F ^a   Guedea, Anita L ^a   Jovasevic, Vladimir ^a   Corcoran, Kevin A ^a   Leaderbrand, Katherine ^a   Nishimori, Katsuhiko ^b   Contractor, Anis ^a   Radulovic, Jelena ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; MESSENGER RNA; METABOTROPIC RECEPTOR 5; OXYTOCIN RECEPTOR; PARVOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; GRM5 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOUBLE DISSOCIATION; GENE DELETION; GENE EXPRESSION; GENE SILENCING; GENETIC MANIPULATION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEPTUM PELLUCIDUM; SOCIAL INTERACTION; VIRUS RECOMBINANT; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; CONDITIONING; FEAR; FEMALE; GENETIC TRANSDUCTION; GENETICS; HUMAN RELATION; METABOLISM; PHYSIOLOGY; RECOGNITION; SEPTUM NUCLEUS; TRANSGENIC MOUSE;

ANALYSIS OF VARIANCE; ANIMALS; CONDITIONING (PSYCHOLOGY); FEAR; FEMALE; GREEN FLUORESCENT PROTEINS; INTERPERSONAL RELATIONS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTOR, METABOTROPIC GLUTAMATE 5; RECEPTORS, OXYTOCIN; RECOGNITION (PSYCHOLOGY); RNA, MESSENGER; SEPTAL NUCLEI; TRANSDUCTION, GENETIC;

EID: 84939253801     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.81     Document Type: Article

References (54)

1. Balconi M, Canavesio Y (2014). High-frequency rTMS on DLPFC increases prosocial attitude in case of decision to support people. Soc Neurosci 9: 82-93.
2. Burket JA, Herndon AL, Winebarger EE, Jacome LF, Deutsch SI (2011). Complex effects of mGluR5 antagonism on sociability and stereotypic behaviors in mice: possible implications for the pharmacotherapy of autism spectrum disorders. Brain Res Bull 86: 152-158.
3. Caldu X, Dreher JC (2007). Hormonal and genetic influences on processing reward and social information. Ann N Y Acad Sci 1118: 43-73.
4. Caldwell HK (2012). Neurobiology of sociability. Adv Exp Med Biol 739: 187-205.
5. Carlson GC (2012). Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders. Pharmacol Biochem Behav 100: 850-854.
6. Carter CS (1998). Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinology 23: 779-818.
7. Clifton NE, Morisot N, Girardon S, Millan MJ, Loiseau F (2013). Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine. Psychopharmacology (Berl) 225: 579-594.
8. Coghlan S, Horder J, Inkster B, Mendez MA, Murphy DG, Nutt DJ (2012). GABA system dysfunction in autism and related disorders: from synapse to symptoms. Neurosci Biobehav Rev 36: 2044-2055.
9. Cosford ND, Roppe J, Tehrani L, Schweiger EJ, Seiders TJ, Chaudary A, Rao S, Varney MA (2003). [3H]-methoxymethyl- MTEP and [3H]-methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor. Bioorg Med Chem Lett 13: 351-354.
10. Crawley JN, Chen T, Puri A, Washburn R, Sullivan TL, Hill JM, Young NB, Nadler JJ, Moy SS, Young LJ, Caldwell HK, Young WS (2007). Social approach behaviors in oxytocin knockout mice: comparison of two independent lines tested in different laboratory environments. Neuropeptides 41: 145-163.
11. Crespi B, Badcock C (2008). Psychosis and autism as diametrical disorders of the social brain. Behav Brain Sci 31: 241-261.
12. de Vrij FM, Levenga J, van der Linde HC, Koekkoek SK, De Zeeuw CI, Nelson DL, Oostra BA, Willemsen R (2008). Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol Dis 31: 127-132.
13. Dolen G, Carpenter RL, Ocain TD, Bear MF (2010). Mechanismbased approaches to treating fragile X. Pharmacol Ther 127: 78-93.
14. Ferguson JN, Young LJ, Hearn EF, MatzukMM, Insel TR,Winslow JT (2000). Social amnesia in mice lacking the oxytocin gene. Nat Genet 25: 284-288.
15. Gao C, Frausto SF, Guedea AL, Tronson NC, Jovasevic V, Leaderbrand K, Corcoran KA, Guzman YF, Swanson GT, Radulovic J (2011). IQGAP1 regulates NR2A signaling, spine density, and cognitive processes. J Neurosci 31: 8533-8542.
16. Gray J, McNaughton N (2000). The Neuropsychology of Anxiety. Oxford University Press: Oxford, UK.
17. Gunaydin LA, Grosenick L, Finkelstein JC, Kauvar IV, Fenno LE, Adhikari A, Lammel S, Mirzabekov JJ, Airan RD, Zalocusky KA, Tye KM, Anikeeva P, Malenka RC, Deisseroth K (2014). Natural neural projection dynamics underlying social behavior. Cell 157: 1535-1551.
18. Guzman YF, Tronson NC, Jovasevic V, Sato K, Guedea AL, Mizukami H, Nishimori K, Radulovic J (2013). Fear-enhancing effects of septal oxytocin receptors. Nat Neurosci 16: 1185-1187.
19. Guzman YF, Tronson NC, Sato K, Mesic I, Guedea AL, Nishimori K, Radulovic J (2014). Role of oxytocin receptors in modulation of fear by social memory. Psychopharmacology (Berl) 231: 2097-2105.
20. Hitti FL, Siegelbaum SA (2014). The hippocampal CA2 region is essential for social memory. Nature 508: 88-92.
21. Insel TR, O'Brien DJ, Leckman JF (1999). Oxytocin, vasopressin, and autism: is there a connection? Biol Psychiatry 45: 145-157.
22. Kaidanovich-Beilin O, Lipina T, Vukobradovic I, Roder J, Woodgett JR (2011). Assessment of social interaction behaviors. J Vis Exp 48: 2473.
23. Kiser D, Steemers B, Branchi I, Homberg JR (2012). The reciprocal interaction between serotonin and social behaviour. Neurosci Biobehav Rev 36: 786-798.
24. Koros E, Rosenbrock H, Birk G, Weiss C, Sams-Dodd F (2007). The selective mGlu5 receptor antagonist MTEP, similar to NMDA receptor antagonists, induces social isolation in rats. Neuropsychopharmacology 32: 562-576.
25. Labrie V, Lipina T, Roder JC (2008). Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology (Berl) 200: 217-230.
26. Lee HJ, Caldwell HK, Macbeth AH, Tolu SG, Young WS 3rd (2008). A conditional knockout mouse line of the oxytocin receptor. Endocrinology 149: 3256-3263.
27. Movsesyan VA, O'Leary DM, Fan L, Bao W, Mullins PG, Knoblach SM, Faden AI (2001). mGluR5 antagonists 2-methyl- 6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)- pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 296: 41-47.
28. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN (2004). Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 3: 287-302.
29. Nakamoto M, Nalavadi V, Epstein MP, Narayanan U, Bassell GJ, Warren ST (2007). Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors. Proc Natl Acad Sci USA 104: 15537-15542.
30. Neumann ID (2008). Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. J Neuroendocrinol 20: 858-865.
31. Nishimori K, Takayanagi Y, Yoshida M, Kasahara Y, Young LJ, Kawamata M (2008). New aspects of oxytocin receptor function revealed by knockout mice: sociosexual behaviour and control of energy balance. Prog Brain Res 170: 79-90.
32. O'Leary DM, Movsesyan V, Vicini S, Faden AI (2000). Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism. Br J Pharmacol 131: 1429-1437.
33. Panksepp J (1992). Oxytocin effects on emotional processes: separation distress, social bonding, and relationships to psychiatric disorders. Ann NY Acad Sci 652: 243-252.
34. Paxinos G, Franklin KB (2004). The Mouse Brain in Stereotaxic Coordinates. Gulf Profesional Publishing: San Diego.
35. Pilakka-Kanthikeel S, Atluri VS, Sagar V, Saxena SK, Nair M (2013). Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study. PLoS One 8: e62241.
36. Pobbe RL, Pearson BL, Defensor EB, Bolivar VJ, Young WS 3rd, Lee HJ, Blanchard DC, Blanchard RJ (2012). Oxytocin receptor knockout mice display deficits in the expression of autism-related behaviors. Horm Behav 61: 436-444.
37. Risold PY, Swanson LW (1997). Connections of the rat lateral septal complex. Brain Res Rev 24: 115-195.
38. Romano C, Sesma MA, McDonald CT, O'Malley K, Van den Pol AN, Olney JW (1995). Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol 355: 455-469.
39. Ross HE, Young LJ (2009). Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front Neuroendocrinol 30: 534-547.
40. Sala M, Braida D, Donzelli A, Martucci R, Busnelli M, Bulgheroni E, Rubino T, Parolaro D, Nishimori K, Chini B (2013). Mice heterozygous for the oxytocin receptor gene (Oxtr(+/- )) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect. J Neuroendocrinol 25: 107-118.
41. Sankoorikal GM, Kaercher KA, Boon CJ, Lee JK, Brodkin ES (2006). A mouse model system for genetic analysis of sociability: C57BL/6J versus BALB/cJ inbred mouse strains. Biol Psychiatry 59: 415-423.
42. Shigemoto R, Nomura S, Ohishi H, Sugihara H, Nakanishi S, Mizuno N (1993). Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett 163: 53-57.
43. Silverman JL, Smith DG, Rizzo SJ, Karras MN, Turner SM, Tolu SS, Bryce DK, Smith DL, Fonseca K, Ring RH, Crawley JN (2012). Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Sci Transl Med 4: 131-151.
44. Silverman JL, Tolu SS, Barkan CL, Crawley JN (2010). Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology 35: 976-989.
45. Teng BL, Nonneman RJ, Agster KL, Nikolova VD, Davis TT, Riddick NV, Baker LK, Pedersen CA, Jarstfer MB, Moy SS (2013). Prosocial effects of oxytocin in two mouse models of autism spectrum disorders. Neuropharmacology 72: 187-196.
46. Thomas AM, Bui N, Graham D, Perkins JR, Yuva-Paylor LA, Paylor R (2011). Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome. Behav Brain Res 223: 310-321.
47. Tronson NC, Guzman YF, Guedea AL, Huh KH, Gao C, Schwarz MK, Radulovic J (2010). Metabotropic glutamate receptor 5/Homer interactions underlie stress effects on fear. Biol Psychiatry 68: 1007-1015.
48. Tronson NC, Schrick C, Guzman YF, Huh KH, Srivastava DP, Penzes P, Guedea AL, Gao C, Radulovic J (2009). Segregated populations of hippocampal principal CA1 neurons mediating conditioning and extinction of contextual fear. J Neurosci 29: 3387-3394.
49. Won H, Lee HR, Gee HY, Mah W, Kim JI, Lee J, Ha S, Chung C, Jung ES, Cho YS, Park SG, Lee JS, Lee K, Kim D, Bae YC, Kaang BK, Lee MG, Kim E (2012). Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486: 261-265.
50. Xu J, Zhu Y, Contractor A, Heinemann SF (2009). mGluR5 has a critical role in inhibitory learning. J Neurosci 29: 3676-3684.
51. Yan QJ, Rammal M, Tranfaglia M, Bauchwitz RP (2005). Suppression of two major Fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49: 1053-1066.
52. Yang P, Chang CL (2014). Glutamate-mediated signaling and autism spectrum disorders: emerging treatment targets. Curr Pharm Des 20: 5186-5193.
53. Yap JJ, Covington HE III, Gale MC, Datta R, Miczek KA (2005). Behavioral sensitization due to social defeat stress in mice: antagonism at mGluR5 and NMDA receptors. Psychopharmacology (Berlin) 179: 230-239.
54. Yoshida M, Takayanagi Y, Inoue K, Kimura T, Young LJ, Onaka T, Nishimori K (2009). Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J Neurosci 29: 2259-2271.